Press Release
21 August 2023
Ashington Innovation plc
("Ashington" or "the Company")
Ashington Announces Dual Listing on the Frankfurt Stock Exchange
Ashington Innovation plc (LSE: ASHI), a special purpose acquisition company ("SPAC") established to acquire businesses primarily in the technology sector, is pleased to announce that it has received approval for its ordinary shares to commence trading on the Frankfurt Stock Exchange ("FSE") under the ticker symbol "6FW". Ashington's FSE information can be found on the Börse Frankfurt website: https://www.boerse-frankfurt.de/en.
The FSE is one of the world's largest international trading centres for securities. Operated by the Deutsche Börse Group, FSE is the largest of Germany's eight stock exchanges, and is responsible for approximately 90 percent of all securities traded in Germany. The FSE facilitates advanced electronic trading, settlement and information systems and enables cross-border trading for international investors.
Following the announcement of Ashington's proposed reverse takeover of Cell Therapy ("the Transaction") on 17 August 2023, the Company's ordinary shares are suspended pending the publication of a prospectus or an announcement that the Transaction is not proceeding.
Jason Smart, Founder of Ashington, said: "We are thrilled to announce the listing of our shares on the Frankfurt Stock Exchange. As one of the largest exchanges in the world, our dual-listing will enhance trading liquidity and facilitate investment in Ashington by institutional and retail investors across Europe."
For further information please contact:
| Ashington Innovation plc | |
| David Orchard General Counsel | via Tancredi +44 207 887 7633 |
| Tancredi Intelligent Communication Media Relations | |
| Helen Humphrey Charlie Hobbs Jasmine Gadhavi ashington@tancredigroup.com | +44 7449 226 720 +44 7897 557 112 +44 7931 435 236 |
About Ashington Innovation plc
Ashington Innovation PLC is a special purpose acquisition company (SPAC), formed with the intention of acquiring businesses operating in the technology sector.
The Company believes that in the increasingly fast-changing global environment there will be an abundance of opportunities to acquire existing businesses in the technology sector, and in particular businesses that possess and utilise proprietary technologies and own applicable intellectual property.
The Company is not limited to any specific geographic region in identifying its target companies.
www.ashingtoninnovationplc.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.